Published online before print August 22, 2002, doi: 10.1161/01.ATV.0000034543.78801.69
© 2002 American Heart Association, Inc.
Atherosclerosis |
Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study
From the Framingham Heart Study (T.J.W., P.W.F.W., P.A.W., D.L., R.B.D., C.J.O.), Framingham, Mass; Cardiology Division (T.J.W., C.J.O.), Massachusetts General Hospital and Department of Radiology (J.F.P.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Mathematics (B.-H.N., R.B.D.), Boston University, Boston, Mass; Departments of Neurology and Preventive Medicine and Epidemiology (P.W.F.W., P.A.W.), Boston University School of Medicine, Boston, Mass; and the National Heart, Lung, and Blood Institute (D.L., C.J.O.), Bethesda, Md.
Correspondence to Christopher J. O’Donnell, MD, MPH, Framingham Heart Study, 73 Mt. Wayte, Suite 2, Framingham, MA 01702-5827. E-mail: chris{at}fram.nhlbi.nih.gov
Abstract
Objective— The objective of this study was to examine the relationship between C-reactive protein (CRP) and carotid atherosclerosis.
Background— Levels of CRP, a nonspecific marker of inflammation, predict risk for cardiovascular events. However, the association between CRP and direct measures of atherosclerosis is not well established.
Methods and Results— Subjects (n=3173, 52% women, mean age 55) in the offspring cohort of the Framingham Heart Study received a CRP measurement and then underwent carotid ultrasonography 4 years later. Carotid stenosis (
25%) was present in 24% of men and 14% of women. Age-adjusted odds ratios for carotid stenosis were 1.62 (95%CI 1.12 to 2.36) for men and 3.90 (CI 2.44 to 6.44) for women in the fourth quartile of CRP compared with those in the lowest quartile. After further adjustment for traditional cardiovascular disease risk factors, the odds ratio remained significant for women (2.97, CI 1.72 to 5.25) but not for men. Similarly, after multivariable adjustment, women in the fourth CRP quartile had a higher mean internal carotid intima-media thickness than those in the lowest CRP quartile (P
0.001). There was no association between common carotid intima-media thickness and CRP.
Conclusions— There is a graded association between CRP and carotid atherosclerosis in women but not in men. The significance of this difference between sexes merits further investigation.
Key Words: C-reactive protein • carotid arteries • carotid stenosis • risk factors • atherosclerosis
High levels of C-reactive protein (CRP) have been shown to predict incident cardiovascular1,2 and cerebrovascular1,3 events. Medications with anti-inflammatory properties may reduce this risk in patients with high CRP levels.4 However, the mechanism underlying the importance of CRP, a nonspecific serum marker of inflammation, remains unclear. Elevated CRP levels may reflect a higher atherosclerotic burden, a higher tendency for plaque rupture and thrombosis, or both.5 An association between CRP and direct measures of atherosclerosis has not been firmly established.
See page 1512
A better understanding of this link may clarify the mechanism by which CRP levels predict future cardiovascular events and have implications for screening potential candidates for anti-inflammatory treatments.
High-resolution B-mode ultrasonography has been used as a noninvasive measure of atherosclerosis. In particular, carotid plaque and intimal medial thickness (IMT) by ultrasound have been shown to correlate with prevalent cardiovascular disease, atherosclerosis in other vascular beds, and incident myocardial infarction and stroke.6–9 Risk factors for carotid atherosclerosis are generally similar to those for coronary heart disease.10,11
The association of carotid disease with CRP has been examined primarily in referral samples or disease cohorts, with some studies12–14 but not others15,16 reporting a positive association. A few studies have been performed in broader samples, and these have not found an association.17,18 Previous reports have assessed atherosclerosis at different sites within the carotid, and it is unclear to what extent the choice of site has influenced the results. In addition, there are conflicting data regarding the influence of sex on the relationship between CRP and atherosclerosis.14,19
The Framingham Heart Study is a community-based cohort in which both CRP measurements and carotid ultrasound tests were obtained in 3173 men and women. We examined the association between CRP and carotid atherosclerosis and investigated whether this association varied by sex or by site of measurement.
Methods
Subjects and Measurements of Risk Factors
The selection criteria and study design of the Framingham Heart Study have been detailed previously.20 Subjects considered for this investigation were participants in the offspring cohort of the Framingham Heart Study, which began in 1971 with the recruitment of 5124 men and women who were offspring and spouses of offspring of the original Framingham Heart Study cohort and ranged in age from 5 to 70 years. There were 3798 participants in offspring study examination cycle 5 (1991 to 1995), and 3696 (97%) received CRP testing. A total of 3173 (86%) of these participants also underwent B-mode carotid ultrasonography during the sixth examination cycle (1995 to 1998); this group formed the main cohort for the analyses.
The medical history and physical examination conducted during the fifth examination cycle was the source of the cardiovascular risk factor data. Persons were classified as current cigarette smokers if they reported having smoked cigarettes during the previous year. Systolic and diastolic blood pressure values were the means of two physician-obtained measurements. Diabetes was defined by history of a fasting glucose 140 mg/dL or use of insulin or hypoglycemic medication. The protocol was approved by the Institutional Review Board of Boston Medical Center.
C-Reactive Protein Measurements
Blood samples were collected from an antecubital vein between 8:00 and 9:00 AM, with subjects supine after an overnight fast. CRP levels were determined by enzyme immunoassay (Hemagen Diagnostics, Inc). Details of the assay have been described previously.3 The correlation coefficient for replicate CRP measurements on 36 subjects was 0.86. Because CRP was used as a categorical predictor in our analyses, we also calculated a kappa statistic to assess between-assay agreement. The kappa value was 0.75 for CRP values in the fourth quartile compared with the first through third quartiles.
Carotid Ultrasonography
Ultrasound studies were acquired and images analyzed according to a standard protocol.10,21 Imaging was conducted using a high-resolution 7.5 Mhz transducer for the common carotid artery and a 5.0 MHz transducer for the carotid bulb and internal carotid artery (Toshiba Medical Systems). Two images were obtained at the level of the distal common carotid artery, 2 at the carotid artery bulb, and 2 in the proximal 2 cm of the internal carotid artery. A single trained sonographer who was blinded to all clinical information made measurements and was over-read by one of the investigators (J.F.P.). Ultrasound studies were conducted on nearly all examination cycle 6 participants (3407 of 3532; 96%).
A subjective estimate was made by the sonographer of the internal carotid artery narrowing, graded as 0%, 1 to 24%, and 25 to 49% when Doppler-derived peak systolic velocities in the internal carotid artery were <150 cm/s. Internal carotid narrowing of hemodynamic significance (50%) was defined as present when peak-systolic velocities in the internal carotid artery were 150 cm/s. For this article, the degree of stenosis was based on the more diseased artery.
Measurements of IMT were made at each of the 3 sites on both sides. The maximal IMT in each site was defined as the mean of the maximal IMT measurements of the near and far walls. The maximal IMT measurement has been shown to correlate well with cardiovascular risk in other studies.6 The internal carotid/bulb IMT was defined as the mean of the 4 maximal IMT measurements for the carotid artery bulb and the internal carotid artery on both sides. The common carotid IMT was defined as the mean of the maximal IMT measurements for the right and left common carotid arteries. All IMT images were gated to diastole.
Statistical Methods
Bivariate analyses were performed comparing the prevalence of coronary heart disease, risk factors for coronary heart disease, and mean CRP in subjects with and without carotid stenosis (assessed at the subsequent examination cycle) using t tests or chi-square tests where appropriate. Comparisons were made between those with 0 to 24% carotid stenosis and those with 25 to 100% carotid stenosis. This cut point has been used in previous carotid ultrasound studies in Framingham and other cohorts.22,23 The kappa value (intra-reader) for 25% carotid stenosis from 158 paired readings on 79 studies was 0.69. Secondary analyses were performed (1) using a cut point of 50% carotid stenosis and (2) comparing subjects with 0% stenosis to those with 25% stenosis.
Both pooled and sex-specific analyses were conducted. Age- and sex-adjusted odds ratios for carotid stenosis were calculated using multivariable logistic regression. Quartiles of CRP were included as categorical predictor variables in the regression analyses. We further adjusted for the effect of traditional risk factors by including the following variables as covariates: smoking, systolic blood pressure, use of antihypertensive therapy, diabetes, body mass index, total/HDL cholesterol ratio, menopausal status, and use of hormone replacement therapy. Secondary analyses were performed after excluding subjects who were using cholesterol-lowering medications because recent evidence suggests that statin medications may reduce CRP levels.4 In similar fashion, we analyzed the adjusted association between CRP quartile and carotid IMT using analysis of covariance. The effect of CRP on internal carotid/bulb IMT and common carotid IMT was analyzed separately.
The SAS System (SAS Institute Inc) was used to perform all statistical analyses. All statistical tests were two-sided and P<0.05 was considered significant.
Results
The mean age of the 3173 subjects was 55 years at examination cycle 5, and 52% of subjects were women. Twenty-four percent of men and 14% of women had carotid stenosis of 25% or greater on ultrasound at examination cycle 6. Age-adjusted baseline characteristics, stratified by the presence of carotid stenosis (25%), are shown in Table 1. Subjects with carotid stenosis had a higher age-adjusted mean CRP (men: 4.81 versus 3.56 mg/L, women: 7.26 versus 4.55 mg/L, P<0.005 for both sexes) and a higher prevalence of cardiovascular disease (Table 1).
|
Overall mean CRP levels were 3.87 and 4.93 mg/L for men and women, respectively. Ten percent of men and 14% of women had CRP levels of 10 mg/L or greater. The quartile ranges for CRP (in mg/L) in men were 0 to 0.34, 0.35 to 1.45, 1.46 to 4.32, and 4.35 to 51 and in women, 0 to 0.28, 0.29 to 1.71, 1.72 to 5.59, and 5.60 to 333.4.
Age-adjusted odds ratios for carotid stenosis by CRP quartile are shown in Table 2. Subjects in the highest quartile of CRP had a significantly greater prevalence of carotid stenosis compared with those in the first quartile (odds ratio, men: 1.62, 95%CI 1.12 to 2.36, women: 3.90, 95%CI 2.44 to 6.44). After multivariable adjustment, the association remained significant in women, with an odds ratio for the fourth quartile of 2.97 (95%CI 1.72 to 5.25), but not in men.
|
We repeated these analyses after excluding subjects with clinically apparent cardiovascular disease at examination cycle 5, when CRP levels were obtained, and the results were similar (Table 3). These results also were similar after the exclusion of subjects who used cholesterol-lowering medications at either examination cycle (odds ratio for women in the fourth CRP quartile 3.24, 95%CI 1.74 to 6.25). Additional analyses were performed using a cut point of 50% carotid stenosis and comparing subjects with 0% versus 25% stenosis. We found odds ratios of similar magnitude but with wider confidence intervals when a cut point of 50% stenosis was used (data not shown).
|
Analyses of the association of CRP with internal carotid/bulb IMT and common carotid IMT are shown in Tables 4 and 5, respectively. In age-adjusted analyses, men and women in the highest CRP quartile had significantly higher mean internal carotid/bulb IMT (P0.0001). After multivariable adjustment, this association remained significant in women (P0.0001) but not in men (P=0.096; Table 4). In the multivariable analyses, total cholesterol was positively associated with internal carotid/bulb IMT in men (P=0.01) and women (P=0.001), and HDL cholesterol had a negative association with internal carotid/bulb IMT in women (P<0.001).
|
|
Similarly, in age-adjusted analyses, subjects in the highest CRP quartile had higher common carotid IMT (Table 5). However, after multivariable adjustment, there were no significant differences in common carotid IMT across quartiles of CRP for either sex.
Discussion
We found that elevated CRP levels were associated with measures of carotid atherosclerosis. This finding persisted, after we adjusted for traditional cardiovascular risk factors, in women but not in men. Even modest elevations of CRP in women predicted a 2- to 3-fold increase in the odds of having carotid stenosis 25%. Similar associations were noted between CRP levels and IMT assessed at the internal carotid artery and carotid bulb.
Previous studies relating CRP levels to carotid atherosclerosis have yielded conflicting results. A positive association has been reported in neurological inpatients,13 dyslipidemic men,14 and ever-smoking women.24 Other studies have found a weak or nonexistent association after adjustment for age and other cardiovascular disease risk factors.15–18,25,26 Differences in study populations may have contributed to the variability in these findings because the majority of studies have been based on patients with specific disease conditions, and some may have been limited by small sample sizes.12–16 Our investigation extends the results of previous studies by examining an unselected cohort of generally healthy middle-aged men and women with a sample size of more than 3000 subjects.
Differences in the site and method of carotid measurement may also account for differences between studies. Some studies focused on the common carotid IMT;12,24 others on the internal carotid IMT;18 and still others on the average IMT in the common carotid artery, carotid bulb, and internal carotid artery.15,17 Thickening may progress at different rates in the common carotid and internal carotid arteries, and associations with risk factors may differ between these sites.9
In our study, a single experienced sonographer and over-reader (J.F.P.) were used and internal and common carotid IMT measures were analyzed separately using well-described methods.10,21 We found that CRP was more strongly associated with internal carotid/bulb IMT than with common carotid IMT. Internal carotid/bulb IMT may be a better marker of early, focal atherosclerosis compared with common carotid IMT because plaques have a greater tendency to form near areas of hemodynamic stress.9,27 Furthermore, in the absence of plaque, common carotid IMT may be influenced by medial thickening rather than intimal thickening.28 Kiechl and Willeit27 have previously reported that risk factors for "focal stenotic disease" (more likely to form in the internal carotid artery) differ from those for nonstenotic atherosclerosis (diffuse predilection); in particular, procoagulant factors, including fibrinogen, which is also an inflammatory marker, were more likely to be associated with stenotic disease. Finally, prospective studies have found internal carotid IMT to be a better predictor of prevalent cardiovascular disease and risk for future cardiac events.6,9
We also analyzed both carotid stenosis and carotid IMT because the determinants of established atherosclerotic plaque may differ from the determinants of early, vascular thickening, even at the same site.25,29 Our findings for carotid stenosis (25%) were similar to those for internal carotid/bulb IMT. A similar pattern was also found when we substituted a more stringent threshold for carotid stenosis (50%), although the confidence intervals were wide because of the low prevalence of this degree of stenosis.
We observed a much stronger association between CRP and carotid atherosclerosis in women than in men, even after adjusting for menopausal status and use of estrogen replacement therapy. This was an unexpected finding given that the association between CRP and clinical end points seems to be strong for both women and men.1,2 It has been reported that estrogen replacement therapy increases CRP levels in postmenopausal women,30 but the influence of sex on the atherosclerotic response to inflammation has not been well characterized. Data from other studies are conflicted over whether and in what direction a patient’s sex modifies the association between CRP and atherosclerosis.14,19 In a dyslipidemic cohort, Blackburn et al14 reported that the association between CRP and carotid plaque was significant in men but not women. However, the focus on advanced plaque (40%) may have contributed to the difference between sexes because only 15 women (3.7%)in that study had stenosis 40%. In a study using electron-beam computed tomography, Newman et al19 observed an unadjusted association between CRP and coronary arterial calcification in women but not men.
In the present investigation, the graded association observed in women, the consistency of the results in several multivariable analyses, and the large sample size argue against the difference in sex being a chance finding. Although further investigation is needed, our findings underscore the importance of sex-specific analyses in future studies involving CRP.
Although the focus of our study was CRP, other inflammatory markers, such as soluble intercellular adhesion molecule-1, interleukin-6, and fibrinogen, may also predict cardiovascular events.2,31–33 There are few data regarding the independent relationship of these markers to subclinical atherosclerosis.29,34–36 Further studies to investigate these associations are warranted.
There were several potential study limitations. The carotid atherosclerosis measures were obtained on average 4 years after the CRP determination. Although the association of CRP with a carotid ultrasound study 4 years later should probably be viewed as a "cross-sectional" association, a measurable degree of plaque progression may occur over this time interval.25,37 Thus, our findings may also reflect an association between CRP and incident atherosclerosis, in addition to prevalent atherosclerosis. Additional studies are needed to examine this temporal relationship in large cohorts using rigorous, reproducible measures of carotid atherosclerosis obtained at baseline and follow-up.
Although the intra-reader reproducibility in our study compared favorably with those of previous studies using ultrasound and conventional angiography,38 misclassification may have occurred in the subjective assessment of carotid stenosis. We performed additional analyses comparing the 0% to the 25 to 100% stenosis categories, reasoning that subjects with mild (1 to 24%) stenosis were at highest risk of being misclassified. Our findings did not differ from those in the main analyses. Because scans were read in a blinded fashion, we believe that misclassification of carotid stenosis would be random and lead to a conservative bias.
In contrast to most1 but not all2 previous studies, we used a commercially available assay rather than an in-house research assay for CRP. Commercial assays may not perform as well as research assays, particularly for the lower range of CRP values, although they may be more representative of assays available for clinical use.2 The kappa statistic of 0.75 suggests that this assay was adequate for separation of CRP values in the highest quartile from those in the lower quartiles, which corresponds to the use of CRP in our analyses. Any misclassification of CRP quartile would be expected to bias our results toward the null. Although it is possible that measurement variation systematically affected men more than women, we believe this is unlikely. As in other studies, few subjects had CRP levels of 10 mg/L or higher, a threshold commonly used to indicate clinically important inflammation.
Although we viewed carotid atherosclerosis as a marker for overall atherosclerotic burden, this disease may progress in other vascular territories, including the coronary circulation, at different rates. The results of this study may not be generalizable to atherosclerosis in other major vascular beds.
In summary, levels of CRP were associated with subsequent measures of carotid atherosclerosis in a large community-based cohort. An increased atherosclerotic burden may explain part of the increased risk of cardiovascular events in individuals, particularly women, with elevated CRP levels. The importance of the sex-related differences that we observed require confirmation in other studies but may have important implications for screening subjects at risk for cardiovascular disease and identifying candidates for anti-inflammatory therapy. In addition, further studies are warranted to determine whether carotid atherosclerosis progression is a useful marker of response to anti-inflammatory treatments.
Acknowledgments
This work was supported by grant NIH/NHLBI N01-HC-25195.
Received May 3, 2002; accepted August 9, 2002.
References
1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336: 973–979.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342: 836–843.
3. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D’Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001; 32: 2575–2579.
4. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM, Jr, and the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 2001; 344: 1959–1965.
5. Kuller LH, Tracy RP. The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2000; 20: 901.
6. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340: 14–22.
7. Allan PL, Mowbray PI, Lee AJ, Fowkes FG. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: the Edinburgh Artery Study. Stroke. 1997; 28: 348–353.
8. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995; 26: 386–391.
9. O’Leary DH, Polak JF, Kronmal RA, Savage PJ, Borhani NO, Kittner SJ, Tracy R, Gardin JM, Price TR, Furberg CD. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke. 1996; 27: 224–231.
10. O’Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, Bommer W, Price TR, Gardin JM, Savage PJ. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke. 1992; 23: 1752–1760.
11. Sharrett AR, Sorlie PD, Chambless LE, Folsom AR, Hutchinson RG, Heiss G, Szklo M. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999; 149: 843–852.
12. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Salvatore ML, Boger R. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol. 2002; 13: 490–496.
13. Winbeck K, Kukla C, Poppert H, Klingelhofer J, Conrad B, Sander D. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery. Cerebrovas Dis. 2002; 13: 57–63.[CrossRef]
14. Blackburn R, Giral P, Bruckert E, Andre JM, Gonbert S, Bernard M, Chapman MJ, Turpin G. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol. 2001; 21: 1962–1968.
15. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999; 42: 51–60.[CrossRef][Medline] [Order article via Infotrieve]
16. Hulthe J, Wikstrand J, Fagerberg B. Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Colch). 2001; 100: 371–378.[Medline] [Order article via Infotrieve]
17. Folsom AR, Pankow JS, Tracy RP, Arnett DK, Peacock JM, Hong Y, Djousse L, Eckfeldt JH. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol. 2001; 88: 112–117.[CrossRef][Medline] [Order article via Infotrieve]
18. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997; 17: 2167–2176.
19. Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH. Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation. 2001; 104: 2679–2684.
20. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979; 110: 281–290.
21. Polak JF, O’Leary DH, Kronmal RA, Wolfson SK, Bond MG, Tracy RP, Gardin JM, Kittner SJ, Price TR, Savage PJ. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology. 1993; 188: 363–370.
22. Kuller LH, Shemanski L, Psaty BM, Borhani NO, Gardin J, Haan MN, O’Leary DH, Savage PJ, Tell GS, Tracy R. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 1995; 92: 720–726.
23. Wilson PW, Hoeg JM, D’Agostino RB, Silbershatz H, Belanger AM, Poehlmann H, O’Leary D, Wolf PA. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med. 1997; 337: 516–522.
24. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, Hofman A, Witteman JC. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999; 19: 1986–1991.
25. Willeit J, Kiechl S, Oberhollenzer F, Rungger G, Egger G, Bonora E, Mitterer M, Muggeo M. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol. 2000; 20: 529–537.
26. Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk. 2002; 9: 97–103.[CrossRef][Medline] [Order article via Infotrieve]
27. Kiechl S, Willeit J. The natural course of atherosclerosis: part I: incidence and progression. Arterioscler Thromb Vasc Biol. 1999; 19: 1484–1490.
28. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002; 20: 159–169.[CrossRef][Medline] [Order article via Infotrieve]
29. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999; 30: 841–850.
30. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 1999; 100: 713–716.
31. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998; 351: 88–92.[CrossRef][Medline] [Order article via Infotrieve]
32. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000; 101: 1767–1772.
33. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311: 501–505.[Abstract]
34. Kato A, Odamaki M, Takita T, Maruyama Y, Kumagai H, Hishida A. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int. 2002; 61: 1143–1152.[CrossRef][Medline] [Order article via Infotrieve]
35. Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubler W, Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol. 1997; 17: 505–512.
36. Stensland-Bugge E, Bonaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromso study. Atherosclerosis. 2001; 154: 437–448.[CrossRef][Medline] [Order article via Infotrieve]
37. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, Iyama S, Yamanishi H, Matsumoto M, Hori M. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation. 2001; 104: 63–67.
38. O’Leary DH, Bryan FA, Goodison MW, Rifkin MD, Gramiak R, Ball M, Bond MG, Dunn RA, Goldberg BB, Toole JF, Wheeler HG, Gustafson NF, Ekholm S, Raines JK. Measurement variability of carotid atherosclerosis: real-time (B-mode) ultrasonography and angiography. Stroke. 1987; 18: 1011–1017.
This article has been cited by other articles:
 |
|
 |
|
  A. Cartier, M. Cote, I. Lemieux, L. Perusse, A. Tremblay, C. Bouchard, and J.-P. Despres Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1307 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Weerd, J. P. Greving, A. W.F. de Jong, E. Buskens, and M. L. Bots Prevalence of Asymptomatic Carotid Artery Stenosis According to Age and Sex: Systematic Review and Metaregression Analysis Stroke, April 1, 2009; 40(4): 1105 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bo, L. Corsinovi, A. Brescianini, A. Sona, M. Astengo, R. Dumitrache, M. F. Ferrio, L. Pricop, and G. Fonte High-Sensitivity C-Reactive Protein Is Not Independently Associated With Peripheral Subclinical Atherosclerosis Angiology, February 1, 2009; 60(1): 12 - 20. [Abstract] [PDF]
|
|
|
|
|
|
R. R. Das, S. Seshadri, A. S. Beiser, M. Kelly-Hayes, R. Au, J. J. Himali, C. S. Kase, E. J. Benjamin, J. F. Polak, C. J. O'Donnell, et al. Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study Stroke, November 1, 2008; 39(11): 2929 - 2935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Papas, C. K. Maltezos, N. Papanas, G. Kopadis, J. Marakis, E. Maltezos, and E. Bastounis High-Sensitivity CRP Is Correlated With Neurologic Symptoms and Plaque Instability in Patients With Severe Stenosis of the Carotid Bifurcation Vascular and Endovascular Surgery, June 1, 2008; 42(3): 249 - 255. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Dai, A. H. Miller, J. D. Bremner, J. Goldberg, L. Jones, L. Shallenberger, R. Buckham, N. V. Murrah, E. Veledar, P. W. Wilson, et al. Adherence to the Mediterranean Diet Is Inversely Associated With Circulating Interleukin-6 Among Middle-Aged Men: A Twin Study Circulation, January 15, 2008; 117(2): 169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Mullenix, S. R. Steele, M. J. Martin, B. W. Starnes, and C. A. Andersen C-reactive Protein Level and Traditional Vascular Risk Factors in the Prediction of Carotid Stenosis Arch Surg, November 1, 2007; 142(11): 1066 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sander, C. Schulze Horn, C. Briesenick, and D. Sander High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study Stroke, November 1, 2007; 38(11): 2881 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Olsen, T. W. Hansen, M. K. Christensen, F. Gustafsson, S. Rasmussen, K. Wachtell, H. Ibsen, C. Torp-Pedersen, and P. R. Hildebrandt N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur. Heart J., June 1, 2007; 28(11): 1374 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Lorenz, P. Karbstein, H. S. Markus, and M. Sitzer High-Sensitivity C-Reactive Protein Is Not Associated With Carotid Intima-Media Progression: The Carotid Atherosclerosis Progression Study Stroke, June 1, 2007; 38(6): 1774 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ishikawa, Y. Tamura, S. Hoshide, K. Eguchi, S. Ishikawa, K. Shimada, and K. Kario Low-Grade Inflammation Is a Risk Factor for Clinical Stroke Events in Addition to Silent Cerebral Infarcts in Japanese Older Hypertensives: The Jichi Medical School ABPM Study, Wave 1 Stroke, March 1, 2007; 38(3): 911 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dziedzic Systemic inflammatory markers and risk of dementia. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 258 - 262. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Elosua, J. M. Ordovas, L. A. Cupples, C.-Q. Lai, S. Demissie, C. S. Fox, J. F. Polak, P. A. Wolf, R. B. D'Agostino Sr., and C. J. O'Donnell Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study J. Lipid Res., May 1, 2006; 47(5): 990 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ashfaq, J. L. Abramson, D. P. Jones, S. D. Rhodes, W. S. Weintraub, W. C. Hooper, V. Vaccarino, D. G. Harrison, and A. A. Quyyumi The Relationship Between Plasma Levels of Oxidized and Reduced Thiols and Early Atherosclerosis in Healthy Adults J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1005 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Meigs, C. J. O'Donnell, G. H. Tofler, E. J. Benjamin, C. S. Fox, I. Lipinska, D. M. Nathan, L. M. Sullivan, R. B. D'Agostino, and P. W.F. Wilson Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes: The Framingham Offspring Study Diabetes, February 1, 2006; 55(2): 530 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. F. Wilson, B.-H. Nam, M. Pencina, R. B. D'Agostino Sr, E. J. Benjamin, and C. J. O'Donnell C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study Arch Intern Med, November 28, 2005; 165(21): 2473 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kivimaki, D. A. Lawlor, M. Juonala, G. Davey Smith, M. Elovainio, L. Keltikangas-Jarvinen, J. Vahtera, J. S.A. Viikari, and O. T. Raitakari Lifecourse Socioeconomic Position, C-Reactive Protein, and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2197 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Makita, M. Nakamura, and K. Hiramori The Association of C-Reactive Protein Levels With Carotid Intima-Media Complex Thickness and Plaque Formation in the General Population Stroke, October 1, 2005; 36(10): 2138 - 2142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Davi and A Falco Oxidant stress, inflammation and atherogenesis Lupus, September 1, 2005; 14(9): 760 - 764. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, A. Tanaka, N. Oda, S. Okada, S. Ohta, H. Naito, and M. Adachi Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 625 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study Circulation, August 16, 2005; 112(7): 976 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cushman, A. M. Arnold, B. M. Psaty, T. A. Manolio, L. H. Kuller, G. L. Burke, J. F. Polak, and R. P. Tracy C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women: The Cardiovascular Health Study Circulation, July 5, 2005; 112(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamagami, K. Kitagawa, T. Hoshi, S. Furukado, H. Hougaku, Y. Nagai, and M. Hori Associations of Serum IL-18 Levels With Carotid Intima-Media Thickness Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1458 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Zieske, R. P. Tracy, C. A. McMahan, E. E. Herderick, S. Homma, G. T. Malcom, H. C. McGill Jr, J. P. Strong, and for the Pathobiological Determinants of Atheroscle Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1237 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schillinger, M. Exner, W. Mlekusch, S. Sabeti, J. Amighi, R. Nikowitsch, E. Timmel, B. Kickinger, C. Minar, M. Pones, et al. Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS) Circulation, May 3, 2005; 111(17): 2203 - 2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Novo, S. Basili, R. Tantillo, A. Falco, V. Davi, G. Novo, E. Corrado, and G. Davi Soluble CD40L and Cardiovascular Risk in Asymptomatic Low-Grade Carotid Stenosis Stroke, March 1, 2005; 36(3): 673 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Talbott, J. V. Zborowski, M. Y. Boudreaux, K. P. McHugh-Pemu, K. Sutton-Tyrrell, and D. S. Guzick The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6061 - 6067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Diomedi, A. Pietroiusti, M. Silvestrini, B. Rizzato, L. M. Cupini, F. Ferrante, A. Magrini, A. Bergamaschi, A. Galante, and G. Bernardi CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke Neurology, September 14, 2004; 63(5): 800 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Agmon, B. K. Khandheria, I. Meissner, T. M. Petterson, W. M. O'Fallon, D. O. Wiebers, T. J. H. Christianson, J. P. McConnell, J. P. Whisnant, J. B. Seward, et al. C-Reactive Protein and Atherosclerosis of the Thoracic Aorta: A Population-Based Transesophageal Echocardiographic Study Arch Intern Med, September 13, 2004; 164(16): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study Circulation, July 27, 2004; 110(4): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. L. Chapman, J. P. Beilby, B. M. McQuillan, P. L. Thompson, and J. Hung Monocyte Count, But Not C-Reactive Protein or Interleukin-6, Is an Independent Risk Marker for Subclinical Carotid Atherosclerosis Stroke, July 1, 2004; 35(7): 1619 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. J. Mancini, B. Dahlof, and J. Diez Surrogate Markers for Cardiovascular Disease: Structural Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-22 - IV-30. [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker, P. W.F. Wilson, and S. M. Grundy Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk? Circulation, June 15, 2004; 109(23): 2818 - 2825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Fruchart, M. C. Nierman, E. S. G. Stroes, J. J. P. Kastelein, and P. Duriez New Risk Factors for Atherosclerosis and Patient Risk Assessment Circulation, June 15, 2004; 109(23_suppl_1): III-15 - III-19. [Abstract] [Full Text]
|
|
|
|
|
|
A. Segev, S. Kassam, C. E Buller, H. K Lau, J. D Sparkes, P. W Connelly, P. H Seidelin, M. K Natarajan, E. A Cohen, and B. H Strauss Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting Eur. Heart J., June 2, 2004; 25(12): 1029 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Porcu, C. Emanueli, E. Desortes, G. M. Marongiu, F. Piredda, L. Chao, J. Chao, and P. Madeddu Circulating Tissue Kallikrein Levels Correlate With Severity of Carotid Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Pasternak, M. H. Criqui, E. J. Benjamin, F. G. R. Fowkes, E. M. Isselbacher, P. A. McCullough, P. A. Wolf, and Z.-J. Zheng Atherosclerotic Vascular Disease Conference: Writing Group I: Epidemiology Circulation, June 1, 2004; 109(21): 2605 - 2612. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Reilly, M. L. Wolfe, A. R. Localio, and D. J. Rader C-Reactive Protein and Coronary Artery Calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA) Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1851 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Cao, C. Thach, T. A. Manolio, B. M. Psaty, L. H. Kuller, P. H.M. Chaves, J. F. Polak, K. Sutton-Tyrrell, D. M. Herrington, T. R. Price, et al. C-Reactive Protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly: The Cardiovascular Health Study Circulation, July 15, 2003; 108(2): 166 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Blake and P. M. Ridker C-Reactive Protein, Subclinical Atherosclerosis, and Risk of Cardiovascular Events Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1512 - 1513. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||